Home › Trials › NCT05977777
Clinical trial No longer in our active list Interventional Ages 18 and up

Using contrast-enhanced ultrasound to evaluate pancreatic lesions

Official title: Characterization of Pancreatic Lesions Using Dynamic Contrast-enhanced Ultrasound

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05977777 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new ultrasound technique to see if it can help doctors tell the difference between cancerous and non-cancerous growths in the pancreas for better treatment options.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Roma)
Trial IDNCT05977777 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with at least one pancreatic lesion visible on B-mode ultrasound.

Probably not a fit

Patients who are under 18 years of age, have known allergies to ultrasound contrast agents, or have conditions such as heart failure, pregnancy, or lactation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to characterize pancreatic lesions using dynamic contrast-enhanced ultrasound (DCEUS), a technique that allows for objective assessment of vascular enhancement in pancreatic neoplastic diseases. Given the high mortality rate associated with pancreatic cancer and the limitations of current imaging modalities, this research seeks to improve diagnostic accuracy and treatment strategies. Participants will undergo DCEUS to better differentiate between malignant and benign pancreatic lesions, potentially leading to more effective management of the disease.

Why it matters

Potential benefit: If successful, this study could enhance the diagnostic accuracy for pancreatic cancer, leading to earlier detection and improved treatment outcomes for patients.

How similar studies have gone: While there is limited data on the use of DCEUS specifically for pancreatic lesions, advancements in imaging technology suggest potential for success in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion criteria are:

* written informed consent
* at least 18 years of age
* at least one pancreatic lesion visible in B-mode US and investigated trough CEUS

Exclusion criteria:

* less than 18 years of age
* absence of informed consent
* knowm allergy to ultrasound contrast agent
* hearth failure
* pregnancy
* lactation

Where it's running

  • Fondazione Policlinico Gemelli IRCCS
    Roma, Italy     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Pancreatic Cancer 885Fondazione Policlinico Universitario Agostino Gemelli IRCCS 209
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.